2024. Elucidating the Potential Compounds Targeting OPNL1W Through Virtual Screening for the Treatment of Color Blindness. Molecular Medicine Communications. 4, 01 (Jun. 2024), 31–42. DOI:https://doi.org/10.55627/mmc.004.001.0462.